Jes Gerlach

5.7k total citations
117 papers, 4.2k citations indexed

About

Jes Gerlach is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Jes Gerlach has authored 117 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Psychiatry and Mental health, 30 papers in Cellular and Molecular Neuroscience and 24 papers in Neurology. Recurrent topics in Jes Gerlach's work include Schizophrenia research and treatment (72 papers), Neurotransmitter Receptor Influence on Behavior (21 papers) and Bipolar Disorder and Treatment (18 papers). Jes Gerlach is often cited by papers focused on Schizophrenia research and treatment (72 papers), Neurotransmitter Receptor Influence on Behavior (21 papers) and Bipolar Disorder and Treatment (18 papers). Jes Gerlach collaborates with scholars based in Denmark, United States and United Kingdom. Jes Gerlach's co-authors include Dympna Casey, L Peacock, R. Fog, Daniel E. Casey, Uffe Juul Povlsen, Søren Korsgaard, Erik Christensson, A. Randrup, N Reisby and Henrik Lublin and has published in prestigious journals such as American Journal of Psychiatry, The British Journal of Psychiatry and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Jes Gerlach

113 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jes Gerlach Denmark 37 2.9k 1.2k 794 566 536 117 4.2k
Daniel E. Casey United States 31 2.8k 1.0× 721 0.6× 594 0.7× 436 0.8× 468 0.9× 73 4.2k
J.A. Lieberman United States 29 3.2k 1.1× 1.4k 1.2× 511 0.6× 718 1.3× 882 1.6× 50 5.2k
Guy Chouinard Canada 40 3.7k 1.3× 782 0.7× 812 1.0× 1.3k 2.3× 337 0.6× 103 5.8k
George M. Simpson United States 39 3.1k 1.1× 404 0.3× 439 0.6× 889 1.6× 369 0.7× 154 4.4k
William C. Wirshing United States 31 2.8k 1.0× 427 0.4× 297 0.4× 824 1.5× 381 0.7× 90 3.9k
H.Y. Meltzer United States 27 1.9k 0.7× 1.1k 1.0× 184 0.2× 644 1.1× 648 1.2× 67 3.4k
David C. Mamo Canada 36 2.5k 0.9× 1.1k 1.0× 339 0.4× 406 0.7× 584 1.1× 102 4.0k
G. M. Simpson United States 16 3.6k 1.3× 352 0.3× 556 0.7× 792 1.4× 179 0.3× 41 4.4k
G Chouinard Canada 30 1.6k 0.6× 514 0.4× 315 0.4× 631 1.1× 243 0.5× 99 2.9k
William M. Glazer United States 29 2.1k 0.7× 301 0.3× 577 0.7× 644 1.1× 200 0.4× 103 3.0k

Countries citing papers authored by Jes Gerlach

Since Specialization
Citations

This map shows the geographic impact of Jes Gerlach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jes Gerlach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jes Gerlach more than expected).

Fields of papers citing papers by Jes Gerlach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jes Gerlach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jes Gerlach. The network helps show where Jes Gerlach may publish in the future.

Co-authorship network of co-authors of Jes Gerlach

This figure shows the co-authorship network connecting the top 25 collaborators of Jes Gerlach. A scholar is included among the top collaborators of Jes Gerlach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jes Gerlach. Jes Gerlach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brandt‐Christensen, Mette, Maibritt B. Andersen, Anders Fink‐Jensen, Thomas Werge, & Jes Gerlach. (2005). The substituted (S)-3-phenylpiperidine (−)-OSU6162 reduces apomorphine- and amphetamine-induced behaviour in Cebus apella monkeys. Journal of Neural Transmission. 113(1). 11–19. 9 indexed citations
2.
Andersen, Maibritt B., Kjell Fuxé, Thomas Werge, & Jes Gerlach. (2002). The adenosine A2A receptor agonist CGS 21680 exhibits antipsychotic-like activity in Cebus apella monkeys.. PubMed. 13(8). 639–44. 35 indexed citations
3.
Addington, Donald, Jean‐Michel Azorin, Ian R. H. Falloon, et al.. (2002). Clinical issues related to depression in schizophrenia: an international survey of psychiatrists. Acta Psychiatrica Scandinavica. 105(3). 189–195. 42 indexed citations
4.
Siris, Samuel G., Donald Addington, Jean‐Michel Azorin, et al.. (2001). Depression in schizophrenia: recognition and management in the USA. Schizophrenia Research. 47(2-3). 185–197. 108 indexed citations
5.
Hellewell, Jonathan S.E. & Jes Gerlach. (2000). Opportunities and challenges presented by the new generation antipsychotics. International Journal of Psychiatry in Clinical Practice. 4(1). 53–61. 7 indexed citations
6.
Altamura, A. Carlo, Julio Bobes, David Owens, et al.. (2000). Schizophrenia: Diagnosis and continuing treatment. Principles of Practice from the European Expert Panel on the contemporary treatment of schizophrenia. International Journal of Psychiatry in Clinical Practice. 4. 2 indexed citations
7.
Peacock, Linda, Guy Jensen, Katherine L. Nicholson, & Jes Gerlach. (1999). Extrapyramidal side effects during chronic combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys. European Archives of Psychiatry and Clinical Neuroscience. 249(5). 221–226. 8 indexed citations
8.
Glenthøj, Birte, Rasmus Wentzer Licht, & Jes Gerlach. (1998). Vejledende retningslinier for behandling med antipsykotika. Dansk Psykiatrisk Selskab. Klaringsrapport nr. 5. Ugeskrift for Læger. 1 indexed citations
9.
Kane, John M., Eugenio Aguglia, A. Carlo Altamura, et al.. (1998). Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology. 8(1). 55–66. 255 indexed citations
10.
Peacock, L, Henrik Lublin, Jes Gerlach, & Torfinn Solgaard. (1996). Clozapine versus typical antipsychotics a retro- and prospective study of extrapyramidal side effects. Psychopharmacology. 124(1-2). 188–196. 58 indexed citations
11.
Nilsson, Flemming Mørkeberg, et al.. (1996). Digital movement analysis, a new objective method of measuring tardive dyskinesia and drug-induced parkinsonian tremor: acceptability, reliability and validity. European Archives of Psychiatry and Clinical Neuroscience. 246(2). 71–77. 4 indexed citations
12.
Gerlach, Jes & L Peacock. (1995). New antipsychotics: the present status. International Clinical Psychopharmacology. 10(Supplement 3). 39–48. 82 indexed citations
13.
Gerlach, Jes. (1995). Depot neuroleptics in relapse prevention. International Clinical Psychopharmacology. 9. 17–20. 64 indexed citations
14.
Gerlach, Jes, et al.. (1991). Perphenazine decanoate andcis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Psychopharmacology. 105(1). 42–48. 26 indexed citations
15.
Lublin, Henrik, et al.. (1991). Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia. European Neuropsychopharmacology. 1(4). 541–548. 18 indexed citations
16.
Gerlach, Jes & Dympna Casey. (1988). Tardive dyskinesia. Acta Psychiatrica Scandinavica. 77(4). 369–378. 137 indexed citations
17.
Lublin, Henrik & Jes Gerlach. (1988). Behavioural effects of dopamine D-1 and D-2 receptor agonists in monkeys previously treated with haloperidol. European Journal of Pharmacology. 153(2-3). 239–245. 21 indexed citations
18.
Lyon, Nancy & Jes Gerlach. (1988). Perseverative structuring of responses by schizophrenic and affective disorder patients. Journal of Psychiatric Research. 22(4). 261–277. 16 indexed citations
19.
Gerlach, Jes, et al.. (1987). Selective D1 and D2 Receptor Manipulation in Cebus Monkeys: Relevance for Dystonia and Dyskinesia in Humans. Pharmacology & Toxicology. 61(3). 157–161. 38 indexed citations
20.
Gerlach, Jes, et al.. (1985). LE DOGMATIL DANS LES DYSKINESIES TARDIVES. 61(19). 1369–1375. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel E. Casey Breakdown of academic impact, for papers by J.A. Lieberman Breakdown of academic impact, for papers by Guy Chouinard Breakdown of academic impact, for papers by George M. Simpson Breakdown of academic impact, for papers by William C. Wirshing Breakdown of academic impact, for papers by H.Y. Meltzer Breakdown of academic impact, for papers by David C. Mamo Breakdown of academic impact, for papers by G. M. Simpson Breakdown of academic impact, for papers by G Chouinard Breakdown of academic impact, for papers by William M. Glazer
Rankless by CCL
2026